| 000 | 01693 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514173843.0 | ||
| 264 | 0 | _c20040324 | |
| 008 | 200403s 0 0 eng d | ||
| 022 | _a0954-6820 | ||
| 024 | 7 |
_a10.1111/j.1365-2796.2003.01298.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aD'Auria, F | |
| 245 | 0 | 0 |
_aAccumulation of plasma nucleosomes upon treatment with anti-tumour necrosis factor-alpha antibodies. _h[electronic resource] |
| 260 |
_bJournal of internal medicine _cMar 2004 |
||
| 300 |
_a409-18 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 |
_aAutoantibodies _xanalysis |
| 650 | 0 | 4 | _aAutoimmunity |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNucleosomes _xmetabolism |
| 650 | 0 | 4 | _aPlasma |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _ximmunology |
| 700 | 1 | _aRovere-Querini, P | |
| 700 | 1 | _aGiazzon, M | |
| 700 | 1 | _aAjello, P | |
| 700 | 1 | _aBaldissera, E | |
| 700 | 1 | _aManfredi, A A | |
| 700 | 1 | _aSabbadini, M G | |
| 773 | 0 |
_tJournal of internal medicine _gvol. 255 _gno. 3 _gp. 409-18 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2796.2003.01298.x _zAvailable from publisher's website |
| 999 |
_c14594703 _d14594703 |
||